Showing results (861-870 of 4,872) with videos related to
Sort By:
Pageof 488
Urologic Oncology|March 18, 2014
Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinomaDaniel de Oliveira, Marcos F Dall'Oglio, Sabrina T Reis, et al.Urologic Oncology|April 1, 2014
Commentary on "Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer." Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA. Harvard Radiation Oncology Program, Boston, MA.: Cancer 2013;119(9):1729-35. doi: 10.1002/cncr.27956. [Epub 2013 Feb 22]Alexander GottschalkUrologic Oncology|April 1, 2014
Commentary on "A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma." Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Victoria, Australia.: BJU Int 2012;110(11 Pt B):E737-43. doi: 10.1111/j.1464-410X.2012.11550.x. [Epub 2012 Oct 29]Alexander GottschalkUrologic Oncology|April 29, 2008
Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomyMasafumi Kumano, Hideaki Miyake, Mototsugu Muramaki, et al.Urologic Oncology|April 29, 2008
Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vectorDegui Wang, Zhiping Wang, Junqiang Tian, et al.Urologic Oncology|April 29, 2008
The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Gúerin immunotherapyOfer N Gofrit, Dov Pode, Galina Pizov, et al.Urologic Oncology|May 13, 2014
Prognostic effect of serum and tissue YKL-40 levels in bladder cancerStephan Tschirdewahn, Henning Reis, Christian Niedworok, et al.Urologic Oncology|May 3, 2008
Inactivation of p16 by CpG hypermethylation in renal cell carcinomaMarta Vidaurreta, M Luisa Maestro, M Teresa Sanz-Casla, et al.Urologic Oncology|May 3, 2008
Retroperitoneal lymph node mapping with intratesticular injected patent blue dye in ratsSeref Basal, Hasan Cem Irkilata, Ibrahim Yildirim, et al.Pageof 488